| Milwaukee Catholic Home | |
| 2330 N Prospect Ave, Milwaukee, Wisconsin 53211 | |
| (414) 220-4610 | |
| Name | Milwaukee Catholic Home |
|---|---|
| Location | 2330 N Prospect Ave, Milwaukee, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 107 |
| Occupancy Rate | 70.65% |
| Medicare ID (CCN) | 525635 |
| Legal Business Name | Milwaukee Catholic Home, Inc. |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1902804586 |
| Organization Name | MILWAUKEE CATHOLIC HOME, INC. |
| Address | 2330 N Prospect Ave, Milwaukee, WI 53211 |
| Phone Number | 414-220-4610 |
News Archive
Experts who have been investigating the World Health Organization's management of the response to the H1N1 pandemic have announced that they found no evidence that the drug industry influenced the agency's decision making over how to handle the virus. In their draft report that panel of independent experts did acknowledge that the WHO failed to understand and respond to conflicts of interest among experts on its advisory Emergency Committee, which had previously acknowledged their pharmaceutical industry ties.
Respiratory conditions that restrict breathing such as asthma and chronic obstructive pulmonary disease (COPD) are common killers worldwide. But no effective treatments exist to address the major cause of death in these conditions - excess mucus production.
Two large randomised trials published to coincide with the launch of The Lancet Respiratory Medicine provide compelling new evidence that using two types of common asthma medications combined in one inhaler for both preventive and rescue treatment (Single inhaler Maintenance and Reliever Therapy; SMART) is more effective at reducing attacks than guideline-based treatment in adults whose asthma is not well controlled, and is safe and well tolerated.
A synthesized steroid mirroring one naturally made by the dogfish shark prevents the buildup of a lethal protein implicated in some neurodegenerative diseases, reports an international research team studying an animal model of Parkinson's disease.
Research from Diabetes UK has found that – alongside those living with the condition – parents and carers of children and adults with diabetes experience emotional or mental health problems.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Experts who have been investigating the World Health Organization's management of the response to the H1N1 pandemic have announced that they found no evidence that the drug industry influenced the agency's decision making over how to handle the virus. In their draft report that panel of independent experts did acknowledge that the WHO failed to understand and respond to conflicts of interest among experts on its advisory Emergency Committee, which had previously acknowledged their pharmaceutical industry ties.
Respiratory conditions that restrict breathing such as asthma and chronic obstructive pulmonary disease (COPD) are common killers worldwide. But no effective treatments exist to address the major cause of death in these conditions - excess mucus production.
Two large randomised trials published to coincide with the launch of The Lancet Respiratory Medicine provide compelling new evidence that using two types of common asthma medications combined in one inhaler for both preventive and rescue treatment (Single inhaler Maintenance and Reliever Therapy; SMART) is more effective at reducing attacks than guideline-based treatment in adults whose asthma is not well controlled, and is safe and well tolerated.
A synthesized steroid mirroring one naturally made by the dogfish shark prevents the buildup of a lethal protein implicated in some neurodegenerative diseases, reports an international research team studying an animal model of Parkinson's disease.
Research from Diabetes UK has found that – alongside those living with the condition – parents and carers of children and adults with diabetes experience emotional or mental health problems.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 19.73 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.66 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 68.67 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.47 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.98 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 2.43 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.25 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.83 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 15.14 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 89.95 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.52 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 34.2 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15.55 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 3.6 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.83 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 65.6 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 79.45 | 82.93 |
News Archive
Experts who have been investigating the World Health Organization's management of the response to the H1N1 pandemic have announced that they found no evidence that the drug industry influenced the agency's decision making over how to handle the virus. In their draft report that panel of independent experts did acknowledge that the WHO failed to understand and respond to conflicts of interest among experts on its advisory Emergency Committee, which had previously acknowledged their pharmaceutical industry ties.
Respiratory conditions that restrict breathing such as asthma and chronic obstructive pulmonary disease (COPD) are common killers worldwide. But no effective treatments exist to address the major cause of death in these conditions - excess mucus production.
Two large randomised trials published to coincide with the launch of The Lancet Respiratory Medicine provide compelling new evidence that using two types of common asthma medications combined in one inhaler for both preventive and rescue treatment (Single inhaler Maintenance and Reliever Therapy; SMART) is more effective at reducing attacks than guideline-based treatment in adults whose asthma is not well controlled, and is safe and well tolerated.
A synthesized steroid mirroring one naturally made by the dogfish shark prevents the buildup of a lethal protein implicated in some neurodegenerative diseases, reports an international research team studying an animal model of Parkinson's disease.
Research from Diabetes UK has found that – alongside those living with the condition – parents and carers of children and adults with diabetes experience emotional or mental health problems.
› Verified 3 days ago
Eastcastle Pl Bradford Ter Conv Ctr Location: 2505 E Bradford Ave, Milwaukee, Wisconsin 53211 Phone: (414) 963-6151 | |
Jewish Home And Care Center Location: 1414 N Prospect Ave, Milwaukee, Wisconsin 53202 Phone: (414) 276-2627 | |
Villa At Bradley Estates (the) Location: 6735 W Bradley Rd, Milwaukee, Wisconsin 53223 Phone: (414) 354-3300 | |
Maple Ridge Health Services Location: 2730 W Ramsey Ave, Milwaukee, Wisconsin 53221 Phone: (414) 282-2600 | |